7 trends shaping employer benefits strategies in 2026

High operating costs are driving employers toward leaner workforces, with efficiency taking priority over expansion. A recent survey found that 62% of managers reported higher workloads in 2025 due to freezes or reductions in staff.¹ Organizations are consolidating roles, cross-training employees and prioritizing upskilling over new hiring. As teams shrink, benefits teams face higher question volume and employee dissatisfaction with fewer resources — intensifying the need for clearer communication and simplified member navigation. This trend affects benefits in meaningful ways, with brokers, consultants and employers seeking easy-to-access information and materials that can help field member questions and members wanting easy-to-understand coverage.

Employers are regaining leverage in enforcing return-to-office policies as the labor market shifts in their favor. Yet employees continue finding ways to maintain flexibility. According to recent data, 43% of hybrid workers engage in “coffee badging” — the idea of showing up briefly to meet attendance requirements before working remotely.² This dynamic reflects broader tensions around workplace flexibility.

These shifting attendance patterns also influence how employers think about on-site services, wellness initiatives and communication timing. For benefits teams, understanding these patterns can help shape strategies around on-site health services and benefits that support both in-office and remote work arrangements. It’s important to note that successful return-to-office mandates require employers to balance realism and flexibility — allowing some adaptability while ensuring policy compliance and creating an office environment compelling enough to prevent the “coffee badging” trend.

AI is moving from pilot projects to operational reality. Data shows that 92% of companies plan to increase their AI investments over the next 3 years.³ Employers are exploring AI to improve internal efficiencies and employee productivity, enhance communication, service and support to customers, and support employees. Interestingly, employees are 3 times more likely to be using generative AI today than their leaders expect³ — a gap that suggests employers may need to accelerate both AI strategy and employee training to stay competitive. Employers may want to identify employees facing potential AI disruption and focus on expanding their skill sets to ensure future readiness.

It’s also important to note that staying competitive also means looking at and scrutinizing how vendors and health plans are leveraging AI to make sure it’s being used responsibly and in support of their business priorities.

Cost pressures are intensifying across employer health plans. Employers project a median 9% health care cost trend for 2026.⁴ Even with planned design changes, that projection only falls to 7.6%.⁴ These increases are pushing many employers beyond incremental adjustments toward more significant benefit strategy shifts. These pressures are accelerating interest in alternative plan models that emphasize value, navigation and more predictable cost patterns.

Employer enthusiasm for covering GLP-1 drugs for weight loss is meeting financial reality. Among large employers with 5,000 or more workers, 66% reported that covering GLP-1s for weight loss had a significant impact on prescription drug spending.⁵ Focus groups and interviews reveal that virtually every employer cited high drug costs as the primary reason for reevaluating or restricting coverage.⁶ Some organizations that initially offered broad coverage are now implementing stricter criteria or eliminating obesity coverage entirely while maintaining diabetes indications. Brokers, consultants and carrier representatives can be helpful in supporting employers as they consider coverage criteria, model budget scenarios and navigate rapidly evolving clinical guidance. This trend reflects broader tensions between innovation, employee demand and budget sustainability.

Note: With new legislation led by the current administration, more affordable direct-to-consumer GLP-1 medications are becoming increasingly available, which could help relieve some of the pressure employers are feeling.⁶

Specialty oncology spending remains a significant cost driver for employer health plans. Research shows that, in 2023, launch prices exceeded $100,000 per year for 95% of new anticancer therapies.⁷ These costs are creating pressure at a time when employers are trying to stabilize overall spending. Many employers are reassessing cancer Centers of Excellence (COEs) and specialty pharmacy benefit managers to balance innovation with financial sustainability as well as seeking programs that can help better manage and support complex care needs. The collision between breakthrough treatments and cost-containment strategies is forcing difficult conversations about formulary management and how to ensure access to innovation within finite budget constraints.

Mental health has appeared — for the first time — among the top conditions driving employer health care costs.⁸ This shift reflects both increased utilization and the growing recognition of mental health needs across workforces. More than 1 in 8 people globally live with a mental illness, and depression remains a leading driver of time away from work.⁸ Those numbers become more concerning when looking at the U.S.: More than 1 in 5 U.S. adults experience mental illness.⁹ Employers are responding by looking beyond simple access expansion toward strategies that emphasize quality, appropriateness and measurable outcomes, such as when lower severity support may be the most appropriate choice. And vendors are facing greater pressure to demonstrate measurable outcomes — not just rely on access or utilization metrics.